Novel Methylation Biomarkers for Colorectal Cancer Prognosis
Colorectal cancer (CRC) comprises the third most common cancer worldwide and the second regarding number of deaths. In order to make a correct and early diagnosis to predict metastasis formation, biomarkers are an important tool. Although there are multiple signaling pathways associated with cancer...
Guardado en:
Autores principales: | Alvaro Gutierrez, Hannah Demond, Priscilla Brebi, Carmen Gloria Ili |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae4d14f15bcc46308b9d6a4cff2a70f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Colorectal cancer DNA methylation patterns from patients in Manaus, Brazil
por: Almeida,Fabiana Greyce Oliveira, et al.
Publicado: (2015) -
Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Sternschuss Michal, et al.
Publicado: (2021) -
Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
por: Chengwen Zhao, et al.
Publicado: (2021) -
Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer
por: Shen,Xiaogang, et al.
Publicado: (2017) -
Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores
por: Yi Zhu, et al.
Publicado: (2021)